1 / 23

Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN)

Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD. Why does the FDA need CAERS ? What does the FDA want to accomplish?. WHY is the FDA Developing CAERS ?. Recognized Need for an Improved System Combined Old Computer Systems

bruis
Download Presentation

Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD

  2. Why does the FDA needCAERS? What does the FDA want to accomplish?

  3. WHY is the FDA Developing CAERS? • Recognized Need for an Improved System • Combined Old Computer Systems • Security • International Adverse Events • Counter Terrorism Tool

  4. WHAT Does the FDA Want to Accomplish with CAERS? • Address Serious Adverse Events • Track and Monitor Adverse Events • Analyze for Trends (Consumer Complaints) • Speed the Time of Review

  5. What is an Adverse Event? An illness or injury to an individual alleged to be caused by the use of a product. MINIMUM DATA NEEDED • Adverse event • Manufacturer • Injured Person • Report date • CFSAN Product

  6. WhatIs Redacted fromAdverse Event Reports? • All identifying information of Non-FDA people and places Names and addresses Where consumer purchased product • Medical Records Insurance Information Autopsy Numbers Signatures / Initials Date of Birth

  7. What is not Redacted? • Names of Members of Congress • Gender • Age • Date of Death • Manufacturers • FDA tracking numbers • Symptom

  8. A PASSIVE VS. An ACTIVE SYSTEM CAERSis Passive but all Inclusive 7000 Voluntary Adverse Events and Consumer Complaints Mandatory Adverse Event Reporting?

  9. HOW Does CAERS Work? • Daily Downloads (FDA Field and Follow-up) • Phone Calls, 800#s, and Letters • AERS Drug links

  10. Field Accomplishments and Compliance Tracking System (FACTS) • Industry Codes 54 Dietary Supplements 53 Cosmetics 40 Infant and Junior Food Product

  11. WHAT Have We Done So Far with CAERS? • Computer Design Requirements • New Document Management System • Pilot Operations Ongoing • Training • Searching capabilities

  12. Firm Letter Notification (FY-2003) • Informational/Transparency (share knowledge) • Sent to manufacturer address on report or as designated • Only illness or injury • FDA verification and validation (Fraud) • Redacted for personal identifiers • Ask for other industry reports • Disclaimer

  13. Why Did CAERS Remove the Dietary Supplement Adverse Event Website? Limited Resources Not Consumer Friendly Limited Fields/Trends Lack of Accurate Information Hard to Search Updating Problems Concentrate on CAERS

  14. The NewCAERSWebsite • Invite Industry and Consumer Input • Looking for the best information that is useful and meaningful • Case #/firm/product/ingredient/symptom • Cause and effect / FDA opinion?

  15. WHAT’S in CAERS’ FUTURE? • FY-2003 Go Operational by June 2003 Receive FDA field downloads • FY-2004 Build links to Drug AERS Build links to MedWatch • FY-2005 Complete legacy data transfer Build a link to Poison Control • FY-2006 Build Thesauri for Ingredients, Products and Botanicals

More Related